Skip to main content

Rhenman & Partners Asset Management AB

Position in CRL — Charles River Laboratories International, Inc.

CIK 1599882 Stockholm, V7

Position in CRL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$12,972,388
+$8,487,388 QoQ
Shares Held
57,200
+120.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#93
of 570 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $92,380,973 across 7 Diagnostics & Research names. CRL ranks #5 (14.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 CRL
Charles River Laboratories International, Inc.
This page
57,200 $12,972,388

All Filings in CRL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,972,388 57,200
2026-03-31 $4,485,000 26,000
2025-12-31 $4,388,560 22,000
2024-12-31 $2,741,310 14,850
2024-09-30 $7,386,375 37,500
2024-06-30 $7,023,720 34,000
2024-03-31 $3,441,065 12,700
2023-12-31 $8,983,200 38,000
2023-09-30 $8,623,120 44,000